At VasoCollar, we can effectively transform the needs of physicians, carry out innovative and creative ideas, and further standardize engineering specifications. The design and development of medical devices to solve clinical problems quickly and effectively are our core capabilities. Our company focuses on solving critical clinical medical issues—rapidly and effectively joining blood vessels and restoring blood flow. We identified this pain point and combined the expertise of clinical physicians with engineering design. Currently, we have some proof-of-concept data for small vessels (plastic surgery) and applied for 4 patents in the USA, China, and Taiwan from 2020 to now. 2 US provisional patents were filed this year to get the right in advance. This year, Brooke Army Medical Center, a medical center of the U.S. Department of Defense, expressed interest in signing a contract with us to provide innovative large vessel devices aimed at advancing trauma surgery techniques.
The design of vascular anastomosis devices has been discussed since the 19th century. This intricate skill is crucial in various medical disciplines such as trauma, cardiovascular surgery, organ transplantation, and reconstructive surgery. Traditionally, this procedure has been performed manually using a needle and suture, resulting in several drawbacks including prolonged ischemic time, post-procedure complications, and increased operating room time and costs. Our VasoCollar Anastomosis Kits improve the efficiency and convenience of vascular connections in medical procedures. It simplifies the process, saving time and ensuring accurate connections. Similar to quick connectors in firefighting hoses, our system ensures accurate and secure connections of blood vessels, much like how firefighters can rapidly connect water hoses to extinguish fires and save lives.
In current usual surgery, vascular anastomosis was performed in transferring flaps, organ transplantation, tissue reconstruction, amputation, tumor excision, and laparoscopic surgery, and as a consequence, up to 2 million procedures were performed worldwide annually. The market size is up to USD 120B. For example, with the progression of reconstruction surgery, such as circulation reconnection and reconstruction after tumor excision, the number of surgeries will keep surging, bringing up to more than 1.5 million procedures annually. Vascular anastomosis was also performed in organ transplantation widely, including heart, lung, kidney, and flap, resulting in up to 220 thousand procedures each year globally. The 2016 market size of microsurgery in the USA was more than 5 billion US dollars and with rapidly increasing microsurgery, the demand for vascular anastomosis will also become more obvious.